Logo

Immunotherapy

News and reporting on cancer immunotherapy.

Agendia Building Validation Data on ImPrint for Guiding Neoadjuvant Immunotherapy in Breast Cancer
Premium

The firm envisions marketing the 53-gene signature with its existing MammaPrint and BluePrint tests as a comprehensive platform for breast cancer treatment selection.

Blood-Based PD-L1 Tracking Could Offer Improved Response Prediction for Lung Cancer Immunotherapy
Premium

While the results are from a small study, investigators are working to validate them in larger groups, hoping their method can prove itself for clinical use. 

OncoHost Licenses SomaLogic Platform to Develop Tests to Predict Patient Response to Immunotherapies

OncoHost will use the SomaScan platform to develop proteomic tests to also develop strategies to overcome treatment resistance.

InterVenn BioSciences Hits Commercial Phase, Launches Test for Immunotherapy Response in Melanoma
Premium

At the ASCO meeting this week, the firm will present validation data on the test, which predicts response to immune checkpoint inhibitors in advanced melanoma.

OncoHost Raises $35M in Series C Financing

The Israeli firm will use the funds to expand its PROPHETIC trial and support the US commercial launch of the Prophet platform.

Apr 7, 2022

Hummingbird Diagnostics Developing miRNA-Based Immunotherapy Predictor on Heels of Positive Study
Premium

Nov 24, 2021

Netherlands' PamGene Plans to Launch Dx Services for Lung Cancer, Melanoma Treatment Selection
Premium

Nov 11, 2021

Oncocyte Aims to Stand Out in Cancer Therapy Selection Market with 2022 Test Launches
Premium

Sep 21, 2021

Personal Genome Diagnostics, Cleveland Clinic Join Forces to Advance Liquid Biopsy

Aug 18, 2021

FDA Approves GlaxoSmithKline's Jemperli, Roche’s Ventana CDx for dMMR Solid Cancers

Jul 1, 2021

European Consortium Nets €1M for Test to Predict Bladder Cancer Immunotherapy Response

Jun 3, 2021

Oncocyte, Italian Foundation to Investigate DetermaIO in Colorectal Cancer

May 2, 2021

Freenome Eyes New Dx Possibilities for Core Technology as CRC Detection Trial Progresses
Premium

Apr 13, 2021

Cofactor Genomics Begins Multi-Site Clinical Trial for Immunotherapy Prediction Assay

Apr 12, 2021

Singapore, MIT Researchers Develop Immune Response Test to Improve Infectious Disease Diagnosis
Premium

Apr 12, 2021

Oncocyte AACR Data Expands Potential Applications for Immunotherapy Response Predictor

Mar 18, 2021

Oncocyte Details New Expansions Plans With Growing Portfolio of Acquired Tests
Premium

Feb 25, 2021

Natera Revenues Grow 35 Percent in Q4

Feb 2, 2021

Oncocyte to Acquire Chronix Biomedical

Jan 20, 2021

Oncocyte to Raise $25M in Stock Sale to Institutional Investors

Oct 8, 2020

Oncocyte, Fondazione Michelangelo to Evaluate DetermaIO Test for Immunotherapy Response Prediction

Oct 1, 2020

Oncocyte, Chronix Enter Licensing, Collaboration Agreement for Liquid Biopsy Technology

Sep 25, 2020

Natera Cancer Liquid Biopsy Test Coverage to Expand Under New Draft LCD

Sep 10, 2020

HalioDx, FFCD Collaborate for Phase II Metastatic Colorectal Cancer Trial

Aug 5, 2020

Natera Revenues Climb 16 Percent in Q2 Driven by Reproductive Health Business